
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $208.5M | $216.1M | $316.4M | $486.8M | $614.4M | |
Revenue Growth (YoY) | 0.93% | 3.68% | 46.38% | 53.87% | 26.2% | |
Cost of Revenues | $87.2M | $100.6M | $138.8M | $181.5M | $250.2M | |
Gross Profit | $121.3M | $115.5M | $177.6M | $305.3M | $364.2M | |
Gross Profit Margin | 58.19% | 53.45% | 56.13% | 62.71% | 59.27% | |
R&D Expenses | $16M | $11.4M | $22.3M | $34.3M | $44.6M | |
Selling, General & Admin | $65M | $84.3M | $124M | $161.7M | $249.6M | |
Other Inc / (Exp) | -$940K | -$16M | -$8.9M | -$2.7M | -$6.8M | |
Operating Expenses | $136.9M | $143.7M | $203.3M | $255.8M | $361.9M | |
Operating Income | -$15.6M | -$28.2M | -$25.7M | $49.5M | $2.2M | |
Net Interest Expenses | $9.5M | $11.9M | $28.1M | $26.9M | $17.6M | |
EBT. Incl. Unusual Items | -$26M | -$56.1M | -$62.7M | $19.9M | -$22.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$3.4M | -$13.5M | -$14.8M | $1.1M | -$3.7M | |
Net Income to Company | -$22.5M | -$42.6M | -$47.9M | $18.8M | -$18.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$22.5M | -$42.6M | -$47.9M | $18.8M | -$18.5M | |
Basic EPS (Cont. Ops) | -$1.88 | -$3.40 | -$3.05 | $0.86 | -$1.04 | |
Diluted EPS (Cont. Ops) | -$1.88 | -$3.40 | -$3.05 | $0.85 | -$1.04 | |
Weighted Average Basic Share | $12M | $12.6M | $16.3M | $18M | $19.3M | |
Weighted Average Diluted Share | $12M | $12.6M | $16.3M | $18.2M | $19.3M | |
EBITDA | $28.1M | $3.1M | $25M | $106.6M | $63.1M | |
EBIT | -$16.5M | -$44.1M | -$34.6M | $46.8M | -$4.6M | |
Revenue (Reported) | $208.5M | $216.1M | $316.4M | $486.8M | $614.4M | |
Operating Income (Reported) | -$15.6M | -$28.2M | -$25.7M | $49.5M | $2.2M | |
Operating Income (Adjusted) | -$16.5M | -$44.1M | -$34.6M | $46.8M | -$4.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $54.5M | $64.5M | $106.8M | $137.4M | $197.1M | |
Revenue Growth (YoY) | 9.54% | 18.26% | 65.62% | 28.7% | 43.44% | |
Cost of Revenues | $20M | $34.3M | $37.7M | $49.2M | $73M | |
Gross Profit | $34.5M | $30.2M | $69.1M | $88.3M | $124.1M | |
Gross Profit Margin | 63.34% | 46.85% | 64.69% | 64.23% | 62.95% | |
R&D Expenses | $3M | $5.3M | $5.9M | $10.5M | $10.6M | |
Selling, General & Admin | $17.6M | $28.8M | $36.5M | $48M | $76.5M | |
Other Inc / (Exp) | -$515K | -$842K | -$2.1M | $14.9M | $11.4M | |
Operating Expenses | $31.5M | $48.6M | $57.1M | $73.2M | $110M | |
Operating Income | $3M | -$18.4M | $12M | $15.1M | $14.1M | |
Net Interest Expenses | $2.5M | $6.6M | $7.7M | $4.6M | $5.5M | |
EBT. Incl. Unusual Items | $76K | -$25.9M | $2.2M | $25.3M | $20M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$10K | -$5.8M | $726K | $7.1M | $4.3M | |
Net Income to Company | $86K | -$20.1M | $1.4M | $18.2M | $15.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $86K | -$20.1M | $1.4M | $18.2M | $15.7M | |
Basic EPS (Cont. Ops) | $0.01 | -$1.27 | $0.06 | $0.84 | $0.70 | |
Diluted EPS (Cont. Ops) | $0.01 | -$1.27 | $0.06 | $0.82 | $0.69 | |
Weighted Average Basic Share | $12M | $16.1M | $16.4M | $19.1M | $19.6M | |
Weighted Average Diluted Share | $12M | $16.1M | $16.5M | $19.4M | $20M | |
EBITDA | $13.4M | -$4.7M | $24.6M | $44.6M | $48.4M | |
EBIT | $2.5M | -$19.3M | $9.9M | $29.9M | $25.5M | |
Revenue (Reported) | $54.5M | $64.5M | $106.8M | $137.4M | $197.1M | |
Operating Income (Reported) | $3M | -$18.4M | $12M | $15.1M | $14.1M | |
Operating Income (Adjusted) | $2.5M | -$19.3M | $9.9M | $29.9M | $25.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $213.2M | $226.1M | $358.7M | $517.5M | $674.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $85.3M | $114.9M | $142.2M | $193M | $274.1M | |
Gross Profit | $127.9M | $111.2M | $216.5M | $324.5M | $400M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $12.6M | $13.7M | $23M | $38.9M | $44.6M | |
Selling, General & Admin | $68.9M | $95.5M | $131.7M | $173.3M | $278.1M | |
Other Inc / (Exp) | -$1.5M | -$16.3M | -$10.2M | $14.3M | -$10.3M | |
Operating Expenses | $132.6M | $160.9M | $211.8M | $271.9M | $398.7M | |
Operating Income | -$4.7M | -$49.7M | $4.7M | $52.6M | $1.3M | |
Net Interest Expenses | $9.9M | $16.1M | $29.1M | $23.8M | $18.5M | |
EBT. Incl. Unusual Items | -$16M | -$82M | -$34.6M | $43M | -$27.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$571K | -$19.2M | -$8.3M | $7.5M | -$6.5M | |
Net Income to Company | -$15.5M | -$62.8M | -$26.3M | $35.5M | -$21M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$15.5M | -$62.8M | -$26.3M | $35.5M | -$21M | |
Basic EPS (Cont. Ops) | -$1.28 | -$4.53 | -$1.71 | $1.62 | -$1.26 | |
Diluted EPS (Cont. Ops) | -$1.28 | -$4.53 | -$1.71 | $1.58 | -$1.27 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $38.2M | -$15M | $54.3M | $126.7M | $66.9M | |
EBIT | -$6.1M | -$66M | -$5.5M | $66.9M | -$9.1M | |
Revenue (Reported) | $213.2M | $226.1M | $358.7M | $517.5M | $674.1M | |
Operating Income (Reported) | -$4.7M | -$49.7M | $4.7M | $52.6M | $1.3M | |
Operating Income (Adjusted) | -$6.1M | -$66M | -$5.5M | $66.9M | -$9.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $54.5M | $64.5M | $106.8M | $137.4M | $197.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $20M | $34.3M | $37.7M | $49.2M | $73M | |
Gross Profit | $34.5M | $30.2M | $69.1M | $88.3M | $124.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $3M | $5.3M | $5.9M | $10.5M | $10.6M | |
Selling, General & Admin | $17.6M | $28.8M | $36.5M | $48M | $76.5M | |
Other Inc / (Exp) | -$515K | -$842K | -$2.1M | $14.9M | $11.4M | |
Operating Expenses | $31.5M | $48.6M | $57.1M | $73.2M | $110M | |
Operating Income | $3M | -$18.4M | $12M | $15.1M | $14.1M | |
Net Interest Expenses | $2.5M | $6.6M | $7.7M | $4.6M | $5.5M | |
EBT. Incl. Unusual Items | $76K | -$25.9M | $2.2M | $25.3M | $20M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$10K | -$5.8M | $726K | $7.1M | $4.3M | |
Net Income to Company | $86K | -$20.1M | $1.4M | $18.2M | $15.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $86K | -$20.1M | $1.4M | $18.2M | $15.7M | |
Basic EPS (Cont. Ops) | $0.01 | -$1.27 | $0.06 | $0.84 | $0.70 | |
Diluted EPS (Cont. Ops) | $0.01 | -$1.27 | $0.06 | $0.82 | $0.69 | |
Weighted Average Basic Share | $12M | $16.1M | $16.4M | $19.1M | $19.6M | |
Weighted Average Diluted Share | $12M | $16.1M | $16.5M | $19.4M | $20M | |
EBITDA | $13.4M | -$4.7M | $24.6M | $44.6M | $48.4M | |
EBIT | $2.5M | -$19.3M | $9.9M | $29.9M | $25.5M | |
Revenue (Reported) | $54.5M | $64.5M | $106.8M | $137.4M | $197.1M | |
Operating Income (Reported) | $3M | -$18.4M | $12M | $15.1M | $14.1M | |
Operating Income (Adjusted) | $2.5M | -$19.3M | $9.9M | $29.9M | $25.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $7.9M | $100.3M | $48.2M | $221.1M | $144.9M | |
Short Term Investments | -- | -- | -- | -- | $6.3M | |
Accounts Receivable, Net | $95.8M | $128.5M | $165.4M | $162.1M | $221.7M | |
Inventory | $60.8M | $81.7M | $105.4M | $111.2M | $136.8M | |
Prepaid Expenses | -- | $3.7M | $3.8M | -- | -- | |
Other Current Assets | $5.9M | $7.6M | $8.4M | $17.4M | $18M | |
Total Current Assets | $170.3M | $321.8M | $344.3M | $519.8M | $527.7M | |
Property Plant And Equipment | $41.3M | $52.7M | $43.2M | $44.6M | $56.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $3.6M | $27.9M | $28.2M | $28.2M | $60M | |
Other Intangibles | $188.5M | $294.1M | $251.6M | $209M | $541.8M | |
Other Long-Term Assets | $5.8M | $7.2M | -- | -- | -- | |
Total Assets | $461.2M | $771.6M | $760.1M | $904.4M | $1.3B | |
Accounts Payable | $11.3M | $23M | $29.3M | $36.7M | $45.7M | |
Accrued Expenses | $16.7M | $19.4M | $25.6M | $34.1M | $55.1M | |
Current Portion Of Long-Term Debt | $13.2M | $850K | $850K | $850K | $9.2M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | $12.3M | $29K | |
Total Current Liabilities | $78.6M | $87.5M | $99.4M | $145.5M | $193.7M | |
Long-Term Debt | $172.4M | $286.5M | $285.7M | $284.8M | $614.9M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $265.5M | $412.9M | $421.5M | $446.8M | $855.2M | |
Common Stock | $1K | $24.9M | $24.9M | $24.9M | $24.9M | |
Other Common Equity Adj | -$11.4M | -$3.1M | $12.2M | $8.9M | $5.3M | |
Common Equity | $195.7M | $333.9M | $313.7M | $432.7M | $403.7M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $195.7M | $358.7M | $338.5M | $457.6M | $428.5M | |
Total Liabilities and Equity | $461.2M | $771.6M | $760.1M | $904.4M | $1.3B | |
Cash and Short Terms | $7.9M | $100.3M | $48.2M | $221.1M | $151.2M | |
Total Debt | $185.7M | $287.4M | $286.5M | $285.7M | $624.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $25.1M | $76.9M | $67.8M | $228.6M | $149.8M | |
Short Term Investments | -- | -- | -- | $9.7M | $5.4M | |
Accounts Receivable, Net | $91.9M | $131.6M | $174.7M | $172.4M | $220.3M | |
Inventory | $59.9M | $83.2M | $103.7M | $113.8M | $137.4M | |
Prepaid Expenses | -- | $2M | $3.7M | -- | -- | |
Other Current Assets | $5.9M | $7.7M | $6.9M | $16.1M | $23.3M | |
Total Current Assets | $182.8M | $301.4M | $364.8M | $540.6M | $536.3M | |
Property Plant And Equipment | $40.8M | $52.7M | $43.3M | $48.5M | $58.2M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $3.6M | $28.2M | $28.2M | $28.2M | $60.7M | |
Other Intangibles | $178.9M | $281.6M | $238.8M | $196M | $538.5M | |
Other Long-Term Assets | $5.8M | $7.4M | -- | -- | -- | |
Total Assets | $463.8M | $744.8M | $765.2M | $914.5M | $1.3B | |
Accounts Payable | $13.8M | $22.1M | $32.7M | $49.4M | $53.1M | |
Accrued Expenses | $16.4M | $17.7M | $22.4M | $32.4M | $58.4M | |
Current Portion Of Long-Term Debt | $14.4M | $850K | $850K | $850K | $11.2M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | $22.8M | $414K | $229K | |
Total Current Liabilities | $82.8M | $79.5M | $125.8M | $136.9M | $201.8M | |
Long-Term Debt | $169M | $286.3M | $285.5M | $284.6M | $611.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $260.1M | $398.8M | $425.7M | $437.7M | $849M | |
Common Stock | $1K | $24.9M | $24.9M | $24.9M | $24.9M | |
Other Common Equity Adj | -$5M | $2.7M | $11.1M | $9.4M | $3.6M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $203.7M | $346.1M | $339.5M | $476.8M | $443.5M | |
Total Liabilities and Equity | $463.8M | $744.8M | $765.2M | $914.5M | $1.3B | |
Cash and Short Terms | $25.1M | $76.9M | $67.8M | $238.3M | $155.2M | |
Total Debt | $183.4M | $287.2M | $286.3M | $285.5M | $622.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$22.5M | -$42.6M | -$47.9M | $18.8M | -$18.5M | |
Depreciation & Amoritzation | $44.6M | $47.3M | $59.7M | $59.8M | $67.7M | |
Stock-Based Compensation | $12.9M | $10.5M | $14.6M | $20.7M | $29.3M | |
Change in Accounts Receivable | -$23.7M | -$5.5M | -$36.9M | $3.4M | -$21.1M | |
Change in Inventories | -$2.8M | $3.2M | -$23.6M | -$5.8M | -$21.3M | |
Cash From Operations | $15.3M | $3.3M | -$31.2M | $119M | $64M | |
Capital Expenditures | $68.3M | $23.6M | $16.5M | $18.5M | $17M | |
Cash Acquisitions | -- | -$84.5M | -$33K | -- | -$401.3M | |
Cash From Investing | -$68.3M | -$105.5M | -$15.7M | -$18.5M | -$404.7M | |
Dividends Paid (Ex Special Dividend) | -- | -$190K | -$1.6M | -$1.6M | -$1.6M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $15M | $310M | -- | -- | $641.3M | |
Long-Term Debt Repaid | -$15.5M | -$211M | -$3M | -$3M | -$296M | |
Repurchase of Common Stock | -$1.5M | -$890K | -$2M | -$5M | -$11M | |
Other Financing Activities | -- | -- | -- | -$12.5M | -$74.2M | |
Cash From Financing | -$1.4M | $194.6M | -$5.1M | $67.4M | $264.9M | |
Beginning Cash (CF) | $67.4M | $12.9M | $105.3M | $53.2M | $221.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$54.5M | $92.4M | -$52.1M | $167.9M | -$75.8M | |
Ending Cash (CF) | $12.9M | $105.3M | $53.2M | $221.1M | $144.9M | |
Levered Free Cash Flow | -$53.1M | -$20.3M | -$47.7M | $100.4M | $47.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $86K | -$20.1M | $1.4M | $18.2M | $15.7M | |
Depreciation & Amoritzation | $10.9M | $14.6M | $14.7M | $14.7M | $22.9M | |
Stock-Based Compensation | $1.9M | $3.2M | $4.3M | $6.9M | $8.9M | |
Change in Accounts Receivable | $3.9M | -$3.1M | -$9.3M | -$10.3M | $1.8M | |
Change in Inventories | $876K | -$1.5M | $1.7M | -$2.6M | -$625K | |
Cash From Operations | $20.7M | -$18.9M | $21.4M | $18.3M | $35M | |
Capital Expenditures | $737K | $2.2M | $2.4M | $4.6M | $19.8M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$737K | -$2.2M | -$2.4M | $8.9M | -$19.8M | |
Dividends Paid (Ex Special Dividend) | -- | -$405K | -$406K | -$406K | -$406K | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$2.4M | -$750K | -$750K | -$750K | -$2M | |
Repurchase of Common Stock | -$348K | -$1.1M | -$3.5M | -$8.7M | -$10M | |
Other Financing Activities | -- | -- | -- | -$12.5M | -- | |
Cash From Financing | -$2.7M | -$2.3M | -$4.5M | -$19.7M | -$9.9M | |
Beginning Cash (CF) | $12.9M | $105.3M | $53.2M | $221.1M | $144.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -$297K | |
Additions / Reductions | $17.2M | -$23.4M | $14.5M | $7.5M | $5.2M | |
Ending Cash (CF) | $30.1M | $81.9M | $67.8M | $228.6M | $149.8M | |
Levered Free Cash Flow | $19.9M | -$21.1M | $19.1M | $13.7M | $15.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$15.5M | -$62.8M | -$26.3M | $35.5M | -$21M | |
Depreciation & Amoritzation | $44.4M | $50.9M | $59.8M | $59.8M | $75.9M | |
Stock-Based Compensation | $12.4M | $11.9M | $15.7M | $23.2M | $31.3M | |
Change in Accounts Receivable | -$9.5M | -$12.6M | -$43.1M | $2.3M | -$9M | |
Change in Inventories | -$5.6M | $886K | -$20.5M | -$10.2M | -$19.3M | |
Cash From Operations | $34.2M | -$36.3M | $9.2M | $115.8M | $80.7M | |
Capital Expenditures | $11.5M | $25.1M | $16.6M | $20.7M | $32.2M | |
Cash Acquisitions | -- | -$84.5M | -$33K | -- | -$401.3M | |
Cash From Investing | -$11.5M | -$106.9M | -$15.9M | -$7.2M | -$433.5M | |
Dividends Paid (Ex Special Dividend) | -- | -$595K | -$1.6M | -$1.6M | -$1.6M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$17M | -$209.4M | -$3M | -$3M | -$297.3M | |
Repurchase of Common Stock | -$1.4M | -$1.7M | -$4.4M | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$18.1M | $195.1M | -$7.4M | $52.3M | $274.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $4.7M | $51.8M | -$14.2M | $160.8M | -$78M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $22.7M | -$61.4M | -$7.5M | $95.1M | $48.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $86K | -$20.1M | $1.4M | $18.2M | $15.7M | |
Depreciation & Amoritzation | $10.9M | $14.6M | $14.7M | $14.7M | $22.9M | |
Stock-Based Compensation | $1.9M | $3.2M | $4.3M | $6.9M | $8.9M | |
Change in Accounts Receivable | $3.9M | -$3.1M | -$9.3M | -$10.3M | $1.8M | |
Change in Inventories | $876K | -$1.5M | $1.7M | -$2.6M | -$625K | |
Cash From Operations | $20.7M | -$18.9M | $21.4M | $18.3M | $35M | |
Capital Expenditures | $737K | $2.2M | $2.4M | $4.6M | $19.8M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$737K | -$2.2M | -$2.4M | $8.9M | -$19.8M | |
Dividends Paid (Ex Special Dividend) | -- | -$405K | -$406K | -$406K | -$406K | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$2.4M | -$750K | -$750K | -$750K | -$2M | |
Repurchase of Common Stock | -$348K | -$1.1M | -$3.5M | -$8.7M | -$10M | |
Other Financing Activities | -- | -- | -- | -$12.5M | -- | |
Cash From Financing | -$2.7M | -$2.3M | -$4.5M | -$19.7M | -$9.9M | |
Beginning Cash (CF) | $12.9M | $105.3M | $53.2M | $221.1M | $144.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -$297K | |
Additions / Reductions | $17.2M | -$23.4M | $14.5M | $7.5M | $5.2M | |
Ending Cash (CF) | $30.1M | $81.9M | $67.8M | $228.6M | $149.8M | |
Levered Free Cash Flow | $19.9M | -$21.1M | $19.1M | $13.7M | $15.1M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.